Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis

American Journal of Pathology

Volumn 153, Issue 5, 1998, Pages 1459-1466

  Stratmann, Astrid ^a   Risau, Werner ^b   Plate, Karl H ^a,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^c Abteilung Neuropathologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

EID: 0031737425     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65733-1     Document Type: Article

References (47)

1. Kleihues P, Burger PC, Plate KH, Ohgaki H, Cavenee WK. Glioblastoma: Pathology and Genetics of Tumours of the Nervous System. Edited by P Kleihues, WK Cavenee. Lyon, France, International Agency for Research on Cancer, 1997, pp 16-24
2. Brem S, Cotran R, Folkman J: Tumor angiogenesis: a quantitative method for histological grading. J Natl Cancer Inst 1972, 48:347-356
3. Folkman J: Tumor angiogenesis. Adv Cancer Res 1985, 43:175-203
4. Risau W: Mechanisms of angiogenesis. Nature 1997, 386:671-674
5. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 383:73-75
6. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan K, Moore MW: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380: 439-442
7. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995, 376:62-66
8. Fong GH, Rossant J, Gertsenstein M, Breitman ML: Role of the Flt-1 receptor tyrosine kinase in regulating assembly of vascular endothelium. Nature 1995, 376:66-70
9. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845
10. Plate KH, Breier G, Risau W: Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 1994, 4:207-218
11. Plate KH, Breier G, Weich HA, Mennel HD, Risau W: Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 1994, 59:520-529
12. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992, 359:845-847
13. Plate KH, Breier G, Millauer B, Ullrich A, Risau W: Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 1993, 53:5822-5827
14. Kim KJ, Li B, Winer J, Armanini M, Gillet N, Philipps HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993, 362:841-844
15. Borgstrom P, Hillan KJ, Sriramarao P, Ferrara N: Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 1996, 56:4032-4039
16. Cheng SY, Huang HJS, Nagane M, Ji XD, Wang DG, Shih CCY, Arap W, Huang CM, Cavanee WK: Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci USA 1996, 93:8502-8507
17. Saleh M, Stacker SA, Wilks AF: Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 1996, 56:393-401
18. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative flk-1 mutant. Nature 1994, 367:576-579
19. Millauer B, Longhi MP, Plate KH, Shawver LK, Risau W, Ullrich A, Strawn LM: Dominant-negative inhibition of flk-1 suppresses the growth of many tumour types in vivo. Cancer Res 1996, 56:1615-1620
20. Stratmann A, Machein MR, Plate KH: Anti-angiogenic gene therapy of malignant glioma. Acta Neurochir 1997, 68:105-110
21. Skobe M, Rockwell P, Goldstein N, Vosseler S, Fusenig NE: Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 1997, 3:1222-1227
22. Lin P, Sankar S, Shan S, Dewhirst MW, Polverini PJ, Quinn TQ, Peters KG: Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor. Cell Growth Differ 1998, 9:49-58
23. Dumont DJ, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML: Tek, novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells, and their presumptive precursors. Oncogene 1992, 7: 1471-1480
24. Schnürch H, Risau W: Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial lineage. Development 1993, 119:957-968
25. Maisonpierre PC, Goldfarb M, Yancopoulos GD, Gao G: Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family. Oncogene 1993, 8:1631-1637
26. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J: The receptor tyrosine kinase tie is required for integrity and survival of vascular endothelial cells. EMBO J 1995, 14:5884-5891
27. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Quin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995, 376:70-74
28. Dumont DJ, Gradwohl G, Fong G-H, Puri MC, Gertsenstein M, Auerbach A, Breitman ML: Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 1994, 1909, 8:1897
29. Kaipainen A, Vlaykova T, Hatva E, Böhling T, Jekunen A, Pyrhonen S, Alitalo K: Enhanced expression of the tie receptor tyrosine kinase messenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res 1994, 54:6571-6577
30. Hatva E, Kaipainen A, Jääskelainen J, Paetau A, Haltia M, Alitalo K: Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumours. Am J Pathol 1995, 146:368-378
31. Salven P, Joensuu H, Heikkila P, Matikainen MT, Wasenius VM, Alanko A, Alitalo K: Endothelial tie growth factor receptor provides angiogenic marker for assessment of breast cancer angiogenesis. Br J Cancer 1996, 74:69-72
32. Lin P, Polverini P, Dewhirst M, Shan S, Rao PS, Peters K: Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth. J Clin Invest 1997, 100:2072-2078
33. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD: Isolation of angiopoietin-1, a ligand for the tie2 receptor, by secretion-trap expression cloning. Cell 1996, 87:1161-1169
34. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD: Requisite role of angiopoietin-1, a ligand for the tie2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180
35. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin-2, a natural antagonist for tie2 that disrupts in vivo angiogenesis. Science 1997, 277:55-60
36. Folkman J, D'Amore PA: Blood vessel formation: what is its molecular basis? Cell 1996, 87:1153-1155
37. Orlidge A, D'Amore PA: Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 1987, 105:1455-1462
38. Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG: Tie2 expression, and phosphorylation in angiogenic, and quiescent adult tissues: Circ Res 1997, 81:567-574
39. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
40. Enholm B, Paavonen K, Ristimaki A, Gunji Y, Klefstrom J, Kivinen L, Laiho M, Olofsson B, Joukov V, Eriksson U, Alitalo K: Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 1997, 14:2475-2483
41. Hanahan D: Signaling vascular morphogenesis and maintenance. Science 1997, 277:48-50
42. Hermansson M, Nistér M, Betsholz C, Heldin CH, Westermark B, Funa K: Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc Natl Acad Sci USA 1988, 85:7748-7752
43. Sato N, Beitz JG, Kato J, Yamamoto M, Clark JW, Calabresi P, Frackelton Jr., AR: Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol 1993, 142:1119-11130
44. Haddah SF, Moore SA, Schelper RL, Goeken JA: Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme. J Neuropath Exp Neurol 1992, 51:488-492
45. Wesseling P, Schlingenmann RO, Rietveld FJR, Link M, Burger PC, Ruiter DJ: Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopic study. J Neuropath Exp Neurol 1995, 54:304-310
46. Lindahl P, Johansson BR, Levéen P, Betsholtz C: Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997, 277:242-245
47. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W: Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 1998, 8:529-532